Safety and immunogenicity of TETRActHIB (a vaccine combining DTP vaccine and Haemophilus influenzae type B conjugate vaccine) administered to infants at 6, 10 and 14 weeks of age.

@article{Hussey2002SafetyAI,
  title={Safety and immunogenicity of TETRActHIB (a vaccine combining DTP vaccine and Haemophilus influenzae type B conjugate vaccine) administered to infants at 6, 10 and 14 weeks of age.},
  author={Gregory Dudley Hussey and Hester Malan and Jane Hughes and Brian Eley and M. Piollet and Maryline Charrondiere and Emily Sachs},
  journal={South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde},
  year={2002},
  volume={92 1},
  pages={
          53-7
        }
}
The safety and immunogenicity of TETRActHIB (a vaccine combining diphtheria and tetanus toxoids-pertussis vaccine (DTP) with Haemophilus influenzae type b (Hib) conjugate vaccine (polyribosyl ribitol phosphate conjugated to tetanus protein) (PRP-T)) was assessed in 131 Cape Town infants immunized at 6, 10 and 14 weeks of age. Serological responses to all component antigens were measured before the first dose and at 18 weeks of age. In addition, anti-PRP antibodies were measured at 9 and 18… CONTINUE READING